)
Accendra Health (ACH) investor relations material
Accendra Health Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 results fell short of expectations: net revenue was $601.8M, down 13.7% YoY, and Adjusted EBITDA was $47.8M versus $92.2M.
The terminated commercial Payor relationship and sale of a non-core asset weighed on revenue; excluding those impacts, revenue declined 1% YoY.
Management launched a value-creation plan targeting referrals, patient retention, collections and lower operating costs.
Financial highlights
Q3 continuing-operations loss was $18.0M versus $5.6M a year earlier; net loss was $19.7M.
Nine-month revenue was $1.843B, down $210.3M YoY; the terminated commercial Payor contract accounted for $205M of the decline.
Nine-month Adjusted EBITDA was $166.2M versus $284.8M; nine-month continuing-operations loss was $113.5M versus $93.2M.
Nine-month free cash flow was $(21.3)M versus positive $80.0M; Q3 free cash flow was $5.8M versus $29.2M.
Q3 operating income was $1.3M versus $26.5M; SG&A was $249.5M, down $16.4M YoY.
Outlook and guidance
FY 2026 net revenue is expected at the bottom of the prior $2.45B–$2.55B range; Adjusted EBITDA could be up to 30% below the prior $310M midpoint.
Q4 Adjusted EBITDA is expected to be comparable to Q3; patient service equipment CapEx is expected to be meaningfully lower in 2027 than in 2026.
Further details on the value-creation plan, timing and expected financial impact are expected in Q1; the 2027 outlook is planned for early 2027.
- Revenue grew 3.2%, but adjusted EPS fell as Domestic earnings softened and Movianto expanded overseas.ACH
Q4 2012 - Movianto lifted revenue, while domestic softness and costs constrained earnings growth.ACH
Q4 2013 - Revenue growth and acquisitions contrasted with lower earnings and negative operating cash flow.ACH
Q4 2014 - Revenue rose 3.5%; adjusted EPS reached $2.00 as transformation efforts advanced.ACH
Q4 2015 - Record adjusted EPS masked revenue and margin pressure as transformation spending ramps.ACH
Q4 2016 - Revenue and earnings weakened as transformation and acquisitions reshaped the business for 2018.ACH
Q4 2017 - 2018 revenue grew, but impairment charges and distribution pressures drove a $437M net loss.ACH
Q4 2018 - Margin improved and losses narrowed, but pricing pressure, debt, and supply risks persist.ACH
Q4 2019 - PPE-led Global Products growth lifted earnings despite lower distribution revenue and elective procedures.ACH
Q4 2020 - Record 2021 growth, offset by inflation and supply-chain pressure, with Apria expansion pending.ACH
Q4 2021
Next Accendra Health earnings date
Next Accendra Health earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)